Vitale G - Search Results

1

5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4.

Vitale G, Corona P, Loriga M, Carta A, Paglietti G, Giliberti G, Sanna G, Farci P, Marongiu ME, La Colla P. Vitale G, et al. Eur J Med Chem. 2012 Jul;53:83-97. doi: 10.1016/j.ejmech.2012.03.038. Epub 2012 Mar 30. Eur J Med Chem. 2012. PMID: 22513121

2

4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity.

Corona P, Vitale G, Loriga M, Paglietti G, La Colla P, Collu G, Sanna G, Loddo R. Corona P, et al. Among authors: vitale g. Eur J Med Chem. 2006 Sep;41(9):1102-7. doi: 10.1016/j.ejmech.2006.05.015. Epub 2006 Jul 7. Eur J Med Chem. 2006. PMID: 16828932

3

Synthesis and in vitro antitumor activity of new quinoxaline derivatives.

Corona P, Carta A, Loriga M, Vitale G, Paglietti G. Corona P, et al. Among authors: vitale g. Eur J Med Chem. 2009 Apr;44(4):1579-91. doi: 10.1016/j.ejmech.2008.07.025. Epub 2008 Jul 26. Eur J Med Chem. 2009. PMID: 18774202

4

2-Arylbenzimidazoles as antiviral and antiproliferative agents--Part 2.

Vitale G, Corona P, Loriga M, Carta A, Paglietti G, La Colla P, Busonera B, Marongiu E, Collu D, Loddo R. Vitale G, et al. Med Chem. 2009 Nov;5(6):507-16. doi: 10.2174/157340609790170542. Med Chem. 2009. PMID: 19534676

5

Styrylbenzimidazoles. Synthesis and biological activity - part 3.

Vitale G, Corona P, Loriga M, Carta A, Paglietti G, Ibba C, Giliberti G, Loddo R, Marongiu E, La Colla P. Vitale G, et al. Med Chem. 2010 Mar;6(2):70-8. doi: 10.2174/157340610791321514. Med Chem. 2010. PMID: 20470249

6

Quinoxaline derivatives as new inhibitors of coxsackievirus B5.

Carta A, Sanna G, Briguglio I, Madeddu S, Vitale G, Piras S, Corona P, Peana AT, Laurini E, Fermeglia M, Pricl S, Serra A, Carta E, Loddo R, Giliberti G. Carta A, et al. Among authors: vitale g. Eur J Med Chem. 2018 Feb 10;145:559-569. doi: 10.1016/j.ejmech.2017.12.083. Epub 2017 Dec 27. Eur J Med Chem. 2018. PMID: 29339251 Free article.

7

2-Arylbenzimidazoles as antiviral and antiproliferative agents. Part 1.

Vitale G, Carta A, Loriga M, Paglietti G, La Colla P, Busonera B, Collu D, Loddo R. Vitale G, et al. Med Chem. 2008 Nov;4(6):605-15. doi: 10.2174/157340608786241990. Med Chem. 2008. PMID: 18991746

8

Quinoxaline chemistry. Part 10. Quinoxaline 10-oxa-analogues of trimetrexate (TMQ) and of 5,8-dideazafolic acid. Synthesis and evaluation of in vitro anticancer activity.

Vitale G, Corona P, Loriga M, Paglietti G. Vitale G, et al. Farmaco. 1998 Feb;53(2):150-9. doi: 10.1016/s0014-827x(98)00003-2. Farmaco. 1998. PMID: 9604322

9

Quinoxaline chemistry. Part 11. 3-Phenyl-2[phenoxy- and phenoxymethyl]-6(7) or 6,8-substituted quinoxalines and N-[4-(6(7)-substituted or 6,8-disubstituted-3-phenylquinoxalin-2-yl)hydroxy or hydroxymethyl] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase.

Corona P, Vitale G, Loriga M, Paglietti G, Costi MP. Corona P, et al. Among authors: vitale g. Farmaco. 1998 Jul 30;53(7):480-93. doi: 10.1016/s0014-827x(98)00054-8. Farmaco. 1998. PMID: 9836461

10

Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.

Vitale G, Corona P, Loriga M, Paglietti G. Vitale G, et al. Farmaco. 1998 Aug-Sep;53(8-9):594-601. doi: 10.1016/s0014-827x(98)00075-5. Farmaco. 1998. PMID: 10081824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

767 results

Search Page